公开(公告)号：US20220308057A1

公开(公告)日：2022-09-29

申请号：US17675194

申请日：2022-02-18

Applicant: SYSMEX CORPORATION

Inventor： Maria KIRIYAMA ,  Eiya TAMADA ,  Elnaz NAKHAEI ,  Mami ONISHI

IPC: G01N33/573

Abstract: Disclosed is a method of determining onset risk of cardiovascular disease in a subject, the method comprising: capturing, on a solid phase, an extracellular vesicle derived from a blood sample collected from the subject; and measuring alkaline phosphatase activity of the extracellular vesicle, a measured result of the alkaline phosphatase activity being directed for use as an index of the onset risk of cardiovascular disease in the subject.

公开(公告)号：US20210231692A1

公开(公告)日：2021-07-29

申请号：US17154132

申请日：2021-01-21

Applicant: SYSMEX CORPORATION

Inventor： Amane HARADA ,  Katsuhiro MURAKAMI ,  Keiko MIWA ,  Elnaz NAKHAEI

IPC: G01N33/92

Abstract: Disclosed is a method for obtaining information about cognitive function of a subject, comprising contacting lipoprotein in a blood sample of a subject with a labeled lipid and measuring the labeled lipid incorporated into the lipoprotein, wherein the obtained measured value is an indicator of cognitive impairment.